Angelini Ventures is a corporate venture capital (CVC) firm based in Rome. It leverages a global team of 19 innovation experts operating across 7 countries. 

The company creates and invests in startups developing innovative solutions and ideas in the biotech and healthtech sectors, with the aim of identifying, financing, and realizing solutions that transform traditional healthcare models.

It has an investment capital of €300 million, of which over €125 million has already been allocated across 24 investments distributed between Europe and North America.

Approximately 60% of its investments are in the biotech sector, with the remaining 40% in healthtech. Since December 2025, Angelini Ventures has partnered with the European Investment Bank to co-invest €150 million in European biotech, medtech, and healthtech startups.